On Demand Pharmacology CME Course Library
About On Demand Courses
Each course provides a video recording, transcripts, learning materials, a quiz, and a course evaluation form.
Videos and handouts can be easily downloaded for viewing when internet access is not available.
Table of courses can be sorted by selecting a column heading. Selecting the title displays a detailed course page.
ULS Recorded Courses — Generated by scrape_uls_courses_latest.py — 40 courses — 2025-12-18 22:04:48
| Title | Speaker | Date | Hrs | Price | Meta |
|---|---|---|---|---|---|
| Hypertension Care and Cardiovascular Risk Reduction | Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP | 2025-12-11 | 5 | $125 | Learn ACC/AHA hypertension guidelines, lifestyle interventions, CV risk calculators, resistant hypertension management, emerging therapies, and evidence-based prevention strategies. |
| Overcoming Obesity | Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | 2025-12-10 | 3 | $75 | Explore current and emerging obesity pharmacotherapy options, patient selection criteria, adverse effects, and future treatments to support effective weight management. |
| Honing in on Herbal Remedies, | Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | 2025-12-10 | 2 | $50 | Review common herbal supplements, FDA regulation, safety concerns, adverse effects, and clinically significant drug–herbal interactions using evidence-based resources. |
| Innovations in Dyslipidemia Therapy and Cardiovascular Risk Reduction | Dr. Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP | 2025-12-09 | 5 | $125 | Apply ACC/AHA cholesterol guidelines, nonstatin therapies, antiplatelet strategies, and evidence-based treatments for hypercholesterolemia, CAD, PAD, and CV risk reduction. |
| Prescribing Safely: Avoiding Malpractice and Litigation | Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | 2025-10-15 | 1 | $25 | Learn safe prescribing strategies, prevent drug–drug interactions, and review real malpractice cases to reduce legal risk and improve patient safety. |
| Immunization Update 2025 | Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | 2025-10-15 | 2 | $50 | Review 2024 immunization schedules, vaccine benefits and side effects, and evidence-based strategies to address vaccine hesitancy across the lifespan. |
| Pharmacogenomics and Updates in Diabetes Management | Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | 2025-09-18 | 5 | $125 | 5-hour on-demand CME presented by Dr. Chelsea A. Keedy, PharmD, focusing on pharmacogenomics, personalized drug selection, drug–gene interactions, updated diabetes management guidelines with cardiovascular and renal considerations, and the use of continuous glucose monitoring to optimize therapy. Recorded September 19, 2025. |
| Women’s Health and Preventative Medicine | Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | 2025-09-17 | 5 | $125 | 5-hour on-demand CME presented by Dr. Chelsea A. Keedy, PharmD, covering women’s health and preventive medicine, including pregnancy and lactation updates, contraception, hormone replacement therapy, osteoporosis management, and RSV and pneumococcal vaccine recommendations. Recorded September 17, 2025. Valid through September 17, 2028. |
| Psychopharmacology Trends | Dr. Joshua Caballero, Pharm.D., BCPP, FCCP | 2025-08-28 | 1 | $25 | Explore current psychopharmacology trends, including new antidepressants and antipsychotics, their off-label uses, and strategies to recognize and manage polypharmacy. Learn best practices for prescribing and monitoring psychiatric medications in primary care. |
| Pharmacogenomics in Primary Care Therapy | Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | 2025-08-28 | 1 | $25 | Learn how pharmacogenomics personalizes drug therapy, interprets CYP450 testing results, and improves prescribing practices for antidepressants, statins, and more. |
| New Hypertension Guidelines | Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCP | 2025-08-28 | 1 | $25 | On-demand CME course presented by Dr. Joseph Saseen, PharmD, reviewing new hypertension guidelines, first-line treatment preferences, combination therapy strategies, and evidence-based management of resistant hypertension. Recorded August 28, 2025. Valid through August 28, 2028. |
| Hormone Replacement Therapy Update | Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM | 2025-08-28 | 1 | $25 | Stay current on women’s health with updates on pregnancy and lactation care, contraception, menopause therapy, osteoporosis management, and RSV/pneumococcal vaccines. |
| Drug induced Nutrient Depletions | Dr. Sandford Levy, M.D. | 2025-08-28 | 1 | $25 | On-demand CME course presented by Dr. Sandford Levy, MD, examining how commonly prescribed medications contribute to drug-induced nutrient depletions and impact patient nutritional status. Recorded August 28, 2025. Valid through August 28, 2028. |
| Cannabis and Cannabinoid-Based Therapies | Dr. Randell L. Tackett, Ph.D | 2025-08-28 | 1 | $25 | Overview of medical cannabis prescribing regulations and clinical applications, including cannabinoid pharmacokinetics, metabolism, safety considerations, and clinically significant drug–drug interactions. |
| Pain Management | Dr. Stacey Hollen PharmD, BCACP | 2025-08-27 | 4 | $95 | Summary of the 2022 CDC Opioid Prescribing Guideline focusing on safe opioid use, nonopioid pain treatments, risk mitigation, buprenorphine alternatives, and evidence-based management of acute and chronic pain conditions. |
| Immunotherapy and Biologics in Autoimmune Disease | Dr. Dr. Kajal Jain, Pharm.D | 2025-08-27 | 4 | $95 | Overview of monoclonal antibody medications used to treat psoriasis, rheumatoid arthritis, and asthma, including indications, required safety monitoring, adverse effects, and essential patient education for safe and effective therapy. |
| Dental Prophylaxis | Dr. Anna Paritsky DMD, DDS | 2025-08-27 | 4 | $95 | Review American Heart Association and American Dental Association guidelines on dental antibiotic prophylaxis, including which cardiac patients need prophylaxis, which dental procedures require it, and recommended antibiotics and dosages. |
| Antimicrobial Stewardship | Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | 2025-08-27 | 2 | $50 | Learn 2025 best practices in antimicrobial stewardship, including appropriate prescribing during transitions of care and in outpatient settings, updates on newly approved antibiotics and new indications, and evidence-based strategies for assessing and de-labeling self-reported penicillin allergy. |
| Reframing Our Approach to Personalize the Management of Type 2 Diabetes | Cory Jenks PharmD, BCPS, BCACP | 2025-06-11 | 5 | $125 | Learn how hyperinsulinemia and insulin resistance drive the development of type 2 diabetes and how these mechanisms influence diabetes medication choices. Explore evidence supporting Therapeutic Carbohydrate Restriction (TCR), understand best practices for combining lifestyle and medication interventions, and apply critical thinking and evidence-based medicine tools to personalize treatment for patients with T2D. |
| Pharmacological Strategies to Manage Symptoms of Palliative Care Patient | Dr. Gregory L. Holmquist, PharmD, CPE | 2025-06-10 | 5 | $125 | 1. Define what “palliative care” is 2. State common symptoms experienced by palliative care patients 3. Compare and contrast core pharmacological principles 4. Describe best practice for use of common pain medications 5. Propose a pharmacological management strategy for each of the following symptoms: 6. Cite four general principles for medication optimization |
| 2025 New Drug Update Part 1 & 2 | Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP | 2025-04-24 | 10 | $200 | Experience an Exceptional New Drug Update from Patient Outcomes Dr. C. Wayne Weart is an nationally known expert on new drugs and how they compare to existing medications. Dr. Weart helps you to understand the decisions behind the studies that lead to the evidence in the approval process. |
| Major Depression, Anxiety and Sleep Disorders,Off Label Prescribing of Mood Stabilizer | Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2025-02-20 | 3 | $75 | Review evidence-based management of depression, anxiety, and sleep disorders, including off-label mood stabilizer use, guideline-driven therapy, and safe prescribing in primary care. |
| Osteoporosis and Chronic Kidney Disease | Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2025-02-19 | 2 | $50 | Review evidence-based strategies for managing osteoporosis in patients with chronic kidney disease. Earn 2 CME hours with this on-demand course by Dr. Reamer L. Bushardt, PharmD, PA-C. |
| Avoiding Drug Injury in Older Adult & Best Practices in Prescribing Opioids | Dr. Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2025-02-18 | $75 | Explore aging-related pharmacologic changes, polypharmacy tools, high-risk interactions, and evolving U.S. opioid-prescribing guidelines with regulatory best practices. | |
| Improving Safety of Antimicrobials in the Elderly, Mastering Migraine Management, Latest in Pharmacotherapy for Weight Loss | Dr. Christopher M. Bland | Pharm.D., FCCP, FIDSA, BCPS | 2024-12-13 | 5 | $125 | Review antimicrobial safety in older adults, migraine management including CGRP inhibitors, and evidence-based obesity pharmacotherapy with GLP-1 and GIP agents through case-based learning. |
| Opioids, Cannabinoids and Gabapentenoids for Managing Pain | Dr. Gregory L. Holmquist, PharmD, CPE | 2024-12-12 | 5 | $125 | Learn opioid misuse impact, pain management fundamentals, drug mechanisms, benefits vs. risks, safe monitoring, interactions, and naloxone counseling best practices. |
| Drug Update 2025 | Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | 2024-10-09 | 2 | $50 | Review newly approved medications, updated indications, labeling changes, adverse effects, and clinically significant drug–drug interactions in this 2025 drug update course. |
| Drug Update 2024 | Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP | 2024-10-09 | 3 | $75 | Review newly approved medications, updated labeling and indications, adverse effects, and clinically important drug–drug interactions in this comprehensive 2024 drug update course. |
| Pharmacotherapy for Migraine Headaches including Botox for headaches and TMJ | Dr. Christopher M. Bland Pharm.D., FCCP, FIDSA, BCPS | 2024-09-28 | 1 | $25 | 1. Review current older management strategies for migraine headaches. 2. Discuss role of newer agents including botulinum toxin. 3. Examine best practices through case application. |
| An Evidence-Based Approach to Treating T2D in Adults | Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP | 2024-09-28 | 2 | $50 | Learn the 2024 ADA Standards of Care and the evidence behind them. Apply landmark diabetes trial data showing how improved glycemic control reduces complications in type 2 diabetes. Understand the modern shift from A1C-only treatment to an outcome-based approach focused on reducing cardiovascular, heart failure, kidney disease, and obesity risks—especially in older adults with comorbidities. |
| Advances in the Management of Diabetes: Updates in Therapy | Dr. Jennifer M. Trujillo, PharmD, BCPS, CDE, BC-ADM | 2024-09-18 | 5 | $125 | Learn diabetes therapy updates with a focus on cardiovascular risk reduction, hypertension management, and evidence-based prevention strategie |
| Treatment of Anaphylaxis in Primary care and Acute care and Seizures in Acute care | Dr. Andrea Sikora Pharm.D., MSCR, FCCM, BCCCP | 2024-08-29 | 1 | $25 | Learn evidence-based approaches for treating anaphylaxis in primary and acute care settings. Develop effective acute seizure management plans and identify common adverse effects of widely used anti-epileptic medications. |
| Pharmacotherapy of Chronic Kidney Disease | Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS | 2024-08-29 | 2 | $50 | Concise, clinician-focused guide to SGLT2 inhibitors, GLP-1 RAs, finerenone, hyperkalemia therapies, anemia management (iron & ESAs), and CKD-MBD treatments. Includes mechanisms, roles, pros/cons, and quick selection tips. |
| Pharmacotherapy of Chronic Kidney Disease | Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS | 2024-08-29 | 5 | $125 | Learn key mechanisms, roles, pros and cons, and management strategies for CKD therapies including SGLT2 inhibitors, finerenone, loop/thiazide diuretics, hyperkalemia treatments, anemia therapy, CKD-MBD management, and emerging IgA nephropathy drugs. |
| Pharmacotherapy of Alzheimers and Depression treatment and Adult Onset ADHD_ADD | Dr. Joshua Caballero, Pharm.D., BCPP, FCCP | 2024-08-29 | 2 | $50 | A focused 2-hour session with Dr. Caballero covering evidence-based treatment approaches for Alzheimer’s disease, depression, and adult-onset ADHD/ADD. Learn current pharmacologic strategies, diagnostic considerations, and best practices for managing cognitive decline and mood disorders in adults. |
| GI Pharmacology Update | Dr. Peter S. Buch, MD, AGAF, FACP | 2024-08-29 | 4 | $95 | Gain evidence-based training in gastroenterology with modules on IBS, IBD, NAFLD/NASH, Celiac Disease, GERD, Barrett’s, probiotics, C. difficile, H. pylori, abdominal pain, colon cancer screening, diarrhea, constipation, GI bleeding, and diverticulitis. |
| Optimizing Controlled Substances Prescribing to Avoid Drug Injury in Older Adults, and Drug Therapy for Depression | Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2024-06-05 | 5 | $125 | Learn safe controlled substance prescribing, age-related pharmacologic changes, polypharmacy management, depression treatment, and substance use disorder care through case-based sessions. |
| Best Practices in Prescribing Opioids | Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2024-06-04 | 5 | $125 | Focus on safe controlled substance prescribing, opioid risk reduction, age-sensitive dosing, polypharmacy management, and substance use disorder treatment in clinical practice. |
| Pharmacology of GI Conditions | Dr. Peter S. Buch, MD, AGAF, FACP | 2024-02-27 | 15 | $225 | Enhance your GI expertise with evidence-based CME sessions on IBS, IBD, NAFLD/NASH, Celiac Disease, GERD, probiotics, H. pylori, colon cancer screening, chronic diarrhea, constipation, GI bleeding, and diverticular disease. Practical tools for diagnosis and treatment. |
| DEA MATE | Reamer L. Bushardt, PharmD, PA-C, DFAAPA | 2024-01-27 | 10 | $200 | Comprehensive CME course on safe prescribing and addiction medicine. Session 1 focuses on opioid prescribing best practices, regulatory compliance, and preventing drug injury in older adults. Session 2 explores addiction neuroscience, harm reduction, and SBIRT screening tools. Session 3 covers evidence-based treatments for substance use disorders, pharmacotherapy, ASAM criteria, and patient engagement strategies. Ideal for clinicians managing pain, addiction, and controlled substance therapy. |
Accreditation Information
PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists. On-demand courses provide HOME STUDY credit only.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS: This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).
American Academy of Nurse Practitioners (AANP) accepts on demand courses approved for AMA PRA Category 1 Credit™. This program offers Category 2 credit only.
NURSES: University Learning Systems is Approved by the California Board of Registered Nursing, Provider Number CEP 11409, CE Broker: Arkansas, District of Columbia, Florida, Georgia, Kentucky, New Mexico, and West Virginia, Boards of Nursing.
PHYSICIANS: This CME program offers Category 2 credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive MAINPRO-M2 credits for participation in this activity.
PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.